Liquid Biopsy
Grail, a company that aims to use a blood test to spot cancer, has announced a massive round of funding for its experimental approach. A billion dollars sounds like a lot of money. But when your ambitions are as big as the...
As we get ready to flip the calendars over to 2017, a year that seems almost made up from the time I was about 10 in 1980 thinking wasn’t even a real number. By now we were supposed to be flying around in our transport pods with flux...
Previous posts on this matter referenced that even with the funding proposed in the hundreds of millions dollars (estimated $750 million proposal) a lot more would be required. I believe one critic I referenced said that even with that amount...
I love headlines such as these. First it was "Pigeons to Replace Pathologists in Diagnosing Benign from Malignant Tumors" now it is actual computer algorithms that get it right more times than and more so than ordinary surgical pathologists!...
When serum protein biomarker data were used independently, clinical sensitivity and specificity for detection of breast cancer were 74.7% and 77.0%, respectively. When tumor-associated autoantibody data were used independently,...
If immunotherapy has the cancer community riveted on the treatment side, liquid biopsies are equally exciting on the diagnostics end. And IBM is bringing its research heft to bear on the world of liquid biopsy with an intent to build a...
